PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Cigarette smoking and variations in systemic immune and inflammation markers. | 25274579 | Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, Goedert JJ, Chang CM, Engels EA, Caporaso NE, Pinto LA, Hildesheim A, Chaturvedi AK | J Natl Cancer Inst | 2014 | PLCO |
| Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. | 24853549 | Seow WJ, Cawthon RM, Purdue MP, Hu W, Gao YT, Huang WY, Weinstein SJ, Ji BT, Virtamo J, Hosgood HD, Bassig BA, Shu XO, Cai Q, Xiang YB, Min S, Chow WH, Berndt SI, Kim C, Lim U, Albanes D, Caporaso NE, Chanock S, Zheng W, Rothman N, Lan Q | Cancer Res | 2014 | PLCO |
| Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers. | 24858205 | Wallace TA, Downey RF, Seufert CJ, Schetter A, Dorsey TH, Johnson CA, Goldman R, Loffredo CA, Yan P, Sullivan FJ, Giles FJ, Wang-Johanning F, Ambs S, Glynn SA | Carcinogenesis | 2014 | PLCO |
| Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. | 22711227 | Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee YC | Head Neck | 2013 | PLCO |
| Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 22736219 | Vickers AJ, Bennette C, Kibel AS, Black A, Izmirlian G, Stephenson AJ, Bochner B | Cancer | 2013 | PLCO |
| Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial. | 23262924 | Partridge EE, Greenlee RT, Riley TL, Commins J, Ragard L, Xu JL, Buys SS, Prorok PC, Fouad MN | Obstet Gynecol | 2013 | PLCO |
| A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. | 23295781 | Parikh H, Jia J, Zhang X, Chung CC, Jacobs KB, Yeager M, Boland J, Hutchinson A, Burdett L, Hoskins J, Risch HA, Stolzenberg-Solomon RZ, Chanock SJ, Wolpin BM, Petersen GM, Fuchs CS, Hartge P, Amundadottir L | Pancreas | 2013 | PLCO |
| Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. | 22893105 | Pinsky PF, Black A, Grubb R, Crawford ED, Andriole G, Thompson I, Parnes H | Cancer | 2013 | PLCO |
| Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial. | 23065684 | Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD | Int. J. Cancer | 2013 | PLCO |
| An aggregated analysis of hormonal factors and endometrial cancer risk by parity. | 23280123 | Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, Linet MS, Park Y, Schairer C, Visvanathan K, Lacey JV | Cancer | 2013 | PLCO |
| Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. | 23112111 | Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutr… | Cancer Causes Control | 2013 | PLCO |
| Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies. | 23171878 | Chaturvedi AK, Moore SC, Hildesheim A | Am. J. Epidemiol. | 2013 | PLCO |
| Individual variations in serum melatonin levels through time: implications for epidemiologic studies. | 24376664 | Nogueira LM, Sampson JN, Chu LW, Yu K, Andriole G, Church T, Stanczyk FZ, Koshiol J, Hsing AW | PLoS ONE | 2013 | PLCO |
| Telomere length and risk of glioma. | 24231251 | Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De Vivo I, Savage SA | Cancer Epidemiol | 2013 | PLCO |
| The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. | 24115361 | Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK | J. Natl. Cancer Inst. | 2013 | PLCO |
| Prospective study of the relationship between coffee and tea with colorectal cancer risk: the PLCO Cancer Screening Trial. | 23907431 | Dominianni C, Huang WY, Berndt S, Hayes RB, Ahn J | Br. J. Cancer | 2013 | PLCO |
| Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. | 24089460 | Mir MC, Stephenson AJ, Grubb RL, Black A, Kibel AS, Izmirlian G | Cancer Epidemiol. Biomarkers Prev. | 2013 | PLCO |
| Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial. | 23993734 | Hocking WG, Tammemagi MC, Commins J, Oken MM, Kvale PA, Hu P, Ragard LR, Riley TL, Pinsky P, Beck TM, Prorok PC | Lung Cancer | 2013 | PLCO |
| Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. | 23624999 | Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RL, Hofmann JN, Chow WH, Purdue MP | Am. J. Epidemiol. | 2013 | PLCO |
| Association of obesity with cardiovascular disease mortality in the PLCO trial. | 23632233 | Jiang J, Ahn J, Huang WY, Hayes RB | Prev Med | 2013 | PLCO |